Submit Your Best Content to ISPE

ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.  

What We Look For 

iSpeak Blog

The pharmaceutical industry has operated historically through localized and siloed approaches, where individual facilities developed independent procedures, design philosophies and operational practices. While such autonomy offered flexibility and responsiveness to site specific requirements, it has also introduced significant challenges, including duplication of efforts, inconsistency,...

iSpeak Blog

Artificial Intelligence (AI) and machine learning (ML) are reshaping how pharmaceutical organizations understand, develop, manufacture, and control medicinal products. Their potential extends beyond process optimization: AI-derived insights can strengthen pharmaceutical chemistry, manufacturing, and controls (CMC), support process validation, improve quality risk management, and enhance...

iSpeak Blog

Building on the establishment of the ISPE Netherlands Quality Community of Practice (CoP) in 2025, this article reflects on its official launch event, held on 9 June 2026 at the Biotech Training Facility, located in Leiden Bio Science Park in Leiden, the Netherlands. Bringing together more than 50 pharmaceutical professionals, the event explored how quality can evolve beyond traditional...

iSpeak Blog
In a recent episode of ISPE Podcast: Shaping the Future of Pharma[KL4.1], CaiXue Wei, Vice President of Manufacturing and Operations, Global Industrial Affairs at Hepalink, shared how the category award-winning facility was designed to address multiple manufacturing challenges simultaneously, from capacity constraints and sterility assurance to digital coordination and global supply resilience.
iSpeak Blog

For many community college students eyeing a career in the Bay Area’s thriving biotech scene, jumping from the classroom to a first job can feel like a huge leap. With so many career paths out there, it’s tough to know where to start. While bigger four-year universities may have their own industry networking programs, junior colleges often get left out of the picture. That’s where Brunch with...

iSpeak Blog

As pharmaceutical manufacturing facilities grow increasingly digitized and data-rich, the quality of operational decisions depends not on the volume of data collected, but on how well that information is contextualized and shared. Intelligent visual operational systems, which combines human-centered interface design with contextualized, AI-assisted decision support, can fundamentally...

iSpeak Blog

Two firms assessed much the same system in the same month. Both had bought a model that flags chromatograms for analyst review. The first firm treated it as high risk, and it is understandable why: AI, laboratory data, and batch decisions somewhere downstream. They budgeted six months of validation, wrote scripted tests against every function, and built a monitoring program fit for a system...

iSpeak Blog
The pharmaceutical industry is increasingly looking to Artificial intelligence (AI) as a potential solution to some of manufacturing’s most persistent challenges. Organizations are exploring how AI can reduce the effort required to create and review documents, improve right-first-time performance, standardize investigations and other quality processes, accelerate access to knowledge, support...
iSpeak Blog

As reindustrialization accelerates, new facilities are being built—not as replicas of the past but as digitally native, intelligent environments. These modern factories are designed to bridge the long-standing divide between the information technology (IT) world and the physical world, enabling smarter, faster and more resilient operations.

iSpeak Blog

Commercial oligonucleotide therapeutics are emerging at an unprecedented pace. Many of these products employ novel mechanisms of action, often targeting RNA directly rather than proteins, representing a significant shift in therapeutic strategy. This growth is expected to continue as oligonucleotide technologies expand into larger patient populations and new indications.

iSpeak Blog

As pharmaceutical and biopharmaceutical manufacturers face increasing global competition, rising operational costs, and growing regulatory complexity, the need for smarter, more integrated manufacturing strategies has never been greater. Organizations are under pressure to improve efficiency and throughput while maintaining the robust quality systems and operational reliability required in...

iSpeak Blog
Every major transformation in life sciences has been built upon the foundations established by the one before it. The digitization of regulatory dossiers and enterprise documents created accessibility and transparency. The shift toward structured digital records enabled workflow automation, improved compliance, and data-driven decision-making. Now, the emergence of artificial intelligence (AI) is...
iSpeak Blog

The development and deployment of mRNA COVID-19 vaccines accelerated interest in RNA as a therapeutic platform. RNA-based approaches are now being investigated or developed for applications including vaccines, cancer immunotherapies, protein replacement, and gene editing.

Subscribe to ISPE ISpeak Blogs